Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 5.61
-0.09 (-1.58%)
Feb 9, 2026, 2:54 PM EST
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 20.86 million as of February 9, 2026. Its market cap has increased by 135.34% in one year.
Market Cap
20.86M
Enterprise Value
21.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.61
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 20.86M, a decrease of -86.83%. That is a compound annual growth rate of -23.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 21.86M | -45.71% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 35.00M |
| Thiogenesis Therapeutics | 32.40M |
| Microbix Biosystems | 31.17M |
| Resverlogix | 30.21M |
| Telescope Innovations | 29.09M |
| Devonian Health Group | 27.66M |
| Rapid Dose Therapeutics | 19.60M |
| Hemostemix | 17.57M |